Compass Interest Expense History

CMPX Stock  USD 5.45  0.04  0.74%   
This chart shows how Compass Therapeutics's Interest Expense has changed quarter to quarter. Trend direction and speed of change are the main things to watch here. Compass Therapeutics' Interest Expense has trended pulling back in recent periods. Forward projections suggest a move toward approximately 2.8 M. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
 First Reported
2010-12-31
 Previous Quarter
2.7 M
 Current Value
2.8 M
 Quarterly Volatility
842.3 K
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Compass Therapeutics's Interest Expense history shows how this metric has moved over several reporting periods. Looking at the trend helps investors see whether Compass Therapeutics is heading in a stronger or weaker direction and puts the latest reading in context against its own past.

Latest Compass Therapeutics' Interest Expense Growth Pattern

Compass Therapeutics's Interest Expense is charted below. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. The chart below tracks Compass Therapeutics' Interest Expense to show whether it is rising, falling, or flat over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Interest Expense Trend Statistics

Arithmetic Mean 1,297,218
Geometric Mean 1,082,575
Coefficient Of Variation 64.93
Mean Deviation 724,425
Median 767,000
Standard Deviation 842,325
Sample Variance709.5B
Range2.5M
R-Value 0.79
Mean Square Error285B
R-Squared 0.62
Significance 0.0002
Slope 131,710
Total Sum of Squares11.4T

Compass Interest Expense History

20262.8 M
20252.7 M
20222.4 M
2021370 K
2020908 K
20191.2 M

Related Accounts

Last ReportedEnd Of Year Estimate
Interest Expense2.7 M2.8 M
Other Operating Expenses66.1 M52.1 M
Total Operating Expenses72.8 M55.6 M
Total Other Income Expense Net6.3 M6.7 M
Income Tax Expense-2.2 M-2.1 M
Selling And Marketing Expenses9.9 M8.8 M

Methodology, Assumptions & Data Sources

The data below tracks Compass Therapeutics's Interest Expense over time. Year-over-year changes are the easiest way to spot turning points.

Reported values for Compass Therapeutics are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Refresh times depend on source availability. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 6th, 2026